Skip to main content
FinSpry Logo
FinSpry
NRXP logo
NRXP
(NASDAQ)
NRx Pharmaceuticals, Inc.
$3.46-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NRx Pharmaceuticals (NRXP) Stock Price & Financial Analysis

NRx Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.43 - $3.69
52-Week High$5.06
52-Week Low$1.62
Open$3.49
Volume883.35K
Average Volume (3M)1.08M
Market Cap118.63M
Shares Outstanding32.33M
Price to Sales (P/S)51.74
Price to Book (P/B)-8.59
EV/EBITDA-4.84
Revenue (TTM)2.29M
Net Income (TTM)-24.54M
Free Cash Flow (TTM)-14.93M
EPS (TTM)$-0.94
Profit Margin-1070.26%
Operating Margin-746.88%
50-Day MA$3.74
200-Day MA$2.81
52-Week Change36.43%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About NRx Pharmaceuticals

What is the current stock price for NRXP?

As of the latest trading session, NRXP stock trades at $3.67. The 52-week range is $1.62–$5.06, with a day range of $3.42–$3.69.

What is the P/E ratio for NRXP?

The P/E ratio (Price-to-Earnings) for NRXP is shown in the Key Statistics section. This valuation metric helps compare NRx Pharmaceuticals, Inc. to industry peers.

Does NRXP pay dividends?

NRx Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NRXP?

Based on 2 analysts, the consensus for NRXP is Buy.

What is the market cap of NRXP?

NRx Pharmaceuticals's market capitalization is $118.6M, classifying it as a micro-cap company. NRx Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.